BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Treatment
478 results:

  • 1. Metabolic Tumor Volume as Significant Predictor for Chemotherapy Containing PD-L1 Blocker in Extensive Stage Small Cell lung cancer.
    Hashimoto K; Kaira K; Imai H; Miura YU; Shiono A; Mouri A; Yamaguchi OU; Kobayashi K; Kagamu H; Kuji I
    Anticancer Res; 2024 Apr; 44(4):1541-1551. PubMed ID: 38537960
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. An
    Thor M; Lee C; Sun L; Patel P; Apte A; Grkovski M; Shepherd AF; Gelblum DY; Wu AJ; Simone CB; Chaft JE; Rimner A; Gomez DR; Deasy JO; Shaverdian N
    J Nucl Med; 2024 Apr; 65(4):520-526. PubMed ID: 38485270
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Promising Candidate Prognostic Biomarkers in [
    Hovhannisyan-Baghdasarian N; Luporsi M; Captier N; Nioche C; Cuplov V; Woff E; Hegarat N; Livartowski A; Girard N; Buvat I; Orlhac F
    J Nucl Med; 2024 Apr; 65(4):635-642. PubMed ID: 38453361
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Embedding machine learning based toxicity models within radiotherapy treatment plan optimization.
    Maragno D; Buti G; Birbil Şİ; Liao Z; Bortfeld T; den Hertog D; Ajdari A
    Phys Med Biol; 2024 Mar; 69(7):. PubMed ID: 38412530
    [No Abstract]    [Full Text] [Related]  

  • 5. Prediction of Microwave Ablation Recurrence in Pulmonary Malignancies Using Preoperative Computed Tomography Radiomics Models.
    Zhu F; Yang C; Yang J; Mao H; Huang Y; Liu H; Zhao Z
    Curr Med Imaging; 2024; 20():1-26. PubMed ID: 38389378
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Analysis of Individualized Silicone Rubber Bolus Using Fan Beam Computed Tomography in Postmastectomy Radiotherapy: A Dosimetric Evaluation and Skin Acute Radiation Dermatitis Survey.
    Chen XM; Xu CD; Zeng LP; Huang XT; Chen AQ; Liu L; Lin LW; Jia LC; Li H; Jiang XB
    Technol Cancer Res Treat; 2024; 23():15330338241229367. PubMed ID: 38297814
    [No Abstract]    [Full Text] [Related]  

  • 7. Pharmacokinetics, metabolism, excretion and safety of iruplinalkib (WX-0593), a novel ALK inhibitor, in healthy subjects: a phase I human radiolabeled mass balance study.
    Bian Y; Ma S; Yao Q; Hu T; Ge M; Li H; Zheng S; Gu Z; Feng H; Yu Z; Huang C; Zhang H; Zhao L; Miao L
    Expert Opin Investig Drugs; 2024 Jan; 33(1):63-72. PubMed ID: 38224050
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Streamlined pin-ridge-filter design for single-energy proton FLASH planning.
    Ma C; Zhou J; Chang CW; Wang Y; Patel PR; Yu DS; Tian S; Yang X
    Med Phys; 2024 Apr; 51(4):2955-2966. PubMed ID: 38214381
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Mechanisms Behind the Pharmacological Application of Biochanin-A: A review.
    Anuranjana PV; Beegum F; K P D; George KT; Viswanatha GL; Nayak PG; Kanwal A; Kishore A; Shenoy RR; Nandakumar K
    F1000Res; 2023; 12():107. PubMed ID: 38106650
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Unrevealing the therapeutic benefits of radiotherapy and consolidation immunotherapy using ctDNA-defined tumor clonality in unresectable locally advanced non-small cell lung cancer.
    Yang Y; Wang J; Wang J; Zhao X; Zhang T; Yang Y; Pang J; Ou Q; Wu L; Xu X; Xu K; Zhao J; Bai N; Yang P; Wang S; Wang L; Bi N
    Cancer Lett; 2024 Feb; 582():216569. PubMed ID: 38101608
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. CXCR4-directed PET/CT with [
    Dreher N; Hahner S; Fuß CT; Schlötelburg W; Hartrampf PE; Serfling SE; Schirbel A; Samnick S; Higuchi T; Weich A; Lapa C; Rosenwald A; Buck AK; Kircher S; Werner RA
    Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1383-1394. PubMed ID: 38082196
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Evaluation of the Effect of Lorlatinib on CYP2B6, CYP2C9, UGT, and P-Glycoprotein Substrates in Patients with Advanced Non-Small Cell lung cancer.
    Chen J; Bearz A; Kim DW; Mamdani H; Bauman J; Chiari R; Ou SI; Solomon BJ; Soo RA; Felip E; Shaw AT; Thurm H; Clancy JS; Lee K; O'Gorman M; Tanski C; Pithavala YK
    Clin Pharmacokinet; 2024 Feb; 63(2):171-182. PubMed ID: 38079095
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Predictive value of
    Zhang Q; Tao X; Yuan P; Zhang Z; Ying J; Guo L; Li N; Wang S; Li J; Liu Y; Guo W; Zhao S; Wu N
    Cancer Med; 2023 Nov; 12(22):20864-20877. PubMed ID: 37965789
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. An integrated model combined intra- and peritumoral regions for predicting chemoradiation response of non small cell lung cancers based on radiomics and deep learning.
    Ma Y; Li Q
    Cancer Radiother; 2023 Dec; 27(8):705-711. PubMed ID: 37932182
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation.
    Thor M; Fitzgerald K; Apte A; Oh JH; Iyer A; Odiase O; Nadeem S; Yorke ED; Chaft J; Wu AJ; Offin M; Simone Ii CB; Preeshagul I; Gelblum DY; Gomez D; Deasy JO; Rimner A
    Radiother Oncol; 2024 Jan; 190():109983. PubMed ID: 37926331
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Fabrication, in-silico, in-vitro, and in-vivo characterization of transferrin-targeted micelles containing cisplatin and gadolinium for improved theranostic applications in lung cancer therapy.
    Yadav B; Chauhan M; Sonali ; Dinkar R; Shekhar S; Singh RP
    Eur J Pharm Biopharm; 2023 Dec; 193():44-57. PubMed ID: 37866420
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The predictive value of
    Yin X; Li J; Chen B; Liu K; Hu S
    Lung Cancer; 2023 Dec; 186():107389. PubMed ID: 37820538
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Diagnostic Performance of PSMA-Based 18 F-DCFPyL PET/CT in Prostate cancer Patients After Definitive treatment With PSA Level ≤0.2 ng/mL.
    Lu Y; Wilson ZJ; Xu G; Xu Z; Pan T; Wei P
    Clin Nucl Med; 2023 Dec; 48(12):1021-1027. PubMed ID: 37801580
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. CT-based non-invasive identification of the most common gene mutation status in patients with non-small cell lung cancer.
    Chen Z; Gao S; Ding C; Luo T; Xu J; Xu S; Li S
    Med Phys; 2024 Mar; 51(3):1872-1882. PubMed ID: 37706584
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Benefits of Soybean in the Era of Precision Medicine: A Review of Clinical Evidence.
    Kang JH; Dong Z; Shin SH
    J Microbiol Biotechnol; 2023 Dec; 33(12):1552-1562. PubMed ID: 37674385
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 24.